1. Clinical Overview
A fixed-dose combination (FDC) of three distinct pharmacological agents used primarily for the management of functional gastrointestinal disorders (FGIDs) like Irritable Bowel Syndrome (IBS) and related conditions. Clidinium and Dicyclomine are anticholinergic/antispasmodic agents that reduce gastrointestinal smooth muscle spasms and secretions. Chlordiazepoxide is a benzodiazepine anxiolytic that addresses the psychosomatic and anxiety components often associated with these disorders. This combination is indicated for conditions where both visceral hypersensitivity and psychological stress are contributing factors. Its use is now more restricted due to the risk of dependence from the benzodiazepine component.
| Onset | Duration | Bioavailability |
|---|---|---|
| Oral: 30 to 60 minutes for antispasmodic effects; 1 to 2 hours for peak anxiolytic effects. | Approximately 6 to 12 hours, depending on individual metabolism. | Clidinium: ~10-25% (poor due to first-pass metabolism). Chlordiazepoxide: ~100% (well absorbed). Dicyclomine: ~67-73%. |
2. Mechanism of Action
This combination exerts a dual therapeutic effect: 1) Peripheral anticholinergic/antispasmodic action on the GI smooth muscle and glands (Clidinium & Dicyclomine), and 2) Central anxiolytic and mild sedative action (Chlordiazepoxide). The anticholinergics competitively inhibit acetylcholine at muscarinic receptors in the GI tract, reducing tone, amplitude, and frequency of peristaltic contractions, and decreasing gastric secretions. Chlordiazepoxide potentiates the effect of the inhibitory neurotransmitter GABA at the GABA-A receptor in the CNS, producing calming effects which can break the brain-gut axis dysfunction common in functional GI disorders.
3. Indications & Uses
- Irritable Bowel Syndrome (IBS) - especially with predominant abdominal pain/cramping and associated anxiety
- Functional Dyspepsia with significant anxiety component
- Gastrointestinal spasm associated with anxiety neurosis
4. Dosage & Administration
Adult Dosage: One tablet three or four times daily, preferably 30-60 minutes before meals and at bedtime. The dose should be individualized. Maximum: 4 tablets per day. Therapy should be initiated at the lowest effective dose and for the shortest duration possible (typically 2-4 weeks).
Administration: Take orally with a full glass of water. Can be taken with or without food, but taking before meals may improve symptom control during digestion. Do not crush or chew. Avoid taking with alcohol or grapefruit juice.
5. Side Effects
Common side effects may include:
- Dry mouth (xerostomia)
- Blurred vision / difficulty in accommodation
- Drowsiness, sedation
- Dizziness, lightheadedness
- Constipation
- Headache
- Nausea
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Alcohol, Opioids, Barbiturates, other CNS Depressants | Additive CNS and respiratory depression. Increased risk of sedation, dizziness, and accidents. | Major |
| Other Anticholinergics (e.g., Atropine, TCAs, Antihistamines, Antipsychotics) | Additive anticholinergic side effects (dry mouth, constipation, urinary retention, confusion, tachycardia). | Major |
| Potent CYP3A4 Inhibitors (Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | Increased plasma levels and toxicity of Chlordiazepoxide (prolonged sedation, ataxia). | Major |
| CYP3A4 Inducers (Rifampicin, Carbamazepine, Phenytoin, St. John's Wort) | Decreased plasma levels and efficacy of Chlordiazepoxide. | Moderate |
| Levodopa | Reduced gastrointestinal absorption and efficacy of Levodopa. | Moderate |
| Digoxin | Increased bioavailability of Digoxin due to reduced GI motility. | Moderate |
| Metoclopramide | Pharmacological antagonism; reduces prokinetic effect. | Moderate |
7. Patient Counselling
- DO take exactly as prescribed by your doctor. Do not increase dose or duration.
- DO inform all your doctors and dentists you are taking this medicine.
- DO taper the dose gradually under medical supervision when stopping.
- DONT consume alcohol in any form while on this medication.
- DONT drive, operate machinery, or perform hazardous tasks if feeling drowsy or dizzy.
- DONT stop the medicine suddenly.
- DONT take with other sedatives or sleep aids without consulting your doctor.
- DO maintain good oral hygiene to manage dry mouth (sugar-free gum/candy).
8. Toxicology & Storage
Overdose: Manifestations are an extension of pharmacological effects: Severe CNS depression (drowsiness progressing to coma, confusion, ataxia, diminished reflexes), respiratory depression, cardiovascular collapse (hypotension, bradycardia or tachycardia), severe anticholinergic crisis (hyperthermia, hot dry skin, flushed face, dilated pupils, ileus, urinary retention), and paradoxical excitement. Death is usually due to respiratory or cardiovascular failure.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack. Dispose of unused tablets safely; do not flush.